Cutler Group LP Glaukos Corp Put Options Transaction History

Cutler Group LP

11 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Oct 25, 2022	BUY	$46.84 - $58.49 $9,368 - $11,698	200 New	200 $0
Q4 2021 Jan 18, 2022	SELL	$40.27 - $56.99 $153,026 - $216,562	-3,800 Reduced 43.18%	5,000 $5,000
Q3 2021 Oct 26, 2021	BUY	$47.43 - $84.23 $417,384 - $741,224	8,800 New	8,800 $26,000
Q4 2020 Jan 21, 2021	SELL	$48.9 - $75.26 $4,890 - $7,526	-100 Closed	0 $0
Q3 2020 Oct 27, 2020	BUY	$37.23 - $50.97 $3,722 - $5,097	100 New	100 $0
Q3 2019 Oct 28, 2019	SELL	$58.58 - $83.91 $380,770 - $545,415	-6,500 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$63.59 - $78.71 $95,385 - $118,064	1,500 Added 30.0%	6,500 $17,000
Q3 2018 Nov 07, 2018	BUY	$38.13 - $68.37 $186,837 - $335,013	4,900 Added 4900.0%	5,000 $0
Q1 2018 May 11, 2018	SELL	$26.05 - $34.5 $440,245 - $583,050	-16,900 Reduced 99.41%	100 $0
Q4 2017 Jan 17, 2018	SELL	$24.5 - $36.01 $786,450 - $1.16 Million	-32,100 Reduced 65.38%	17,000 $144,000
Q3 2017 Oct 17, 2017	BUY	$31.26 - $42.03 $1.53 Million - $2.06 Million	49,100	49,100 $280,000

340

47.1M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $6.85B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.